Summary

The global Veterinary Diagnostic Imaging market is projected to grow from US$ 1346 million in 2025 to US$ 2150 million by 2032, at a CAGR of 6.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Veterinary Diagnostic Imaging refers to medical imaging equipment and integrated imaging systems used to visualize anatomical structures, physiological functions and pathological changes in animals for clinical diagnosis, treatment planning, procedural guidance and disease monitoring. The market primarily covers veterinary digital radiography, ultrasound imaging, computed tomography (CT), magnetic resonance imaging (MRI), fluoroscopy, and nuclear medicine or scintigraphy systems, together with the image acquisition, processing and workflow software directly integrated with these systems. Veterinary Diagnostic Imaging serves companion animals, equine patients, livestock and other animal populations across veterinary hospitals, clinics, specialty and referral centers, diagnostic imaging facilities, universities, research institutions and selected field-care environments. Equipment may be fixed, mobile, portable or handheld and may either be purpose-built for veterinary applications or adapted and optimized for animal anatomy, positioning and clinical workflows. Veterinary-specific system design increasingly emphasizes species-oriented imaging protocols, compact installation, mobility, rapid image acquisition, DICOM/PACS compatibility and simplified clinical operation, reflecting the substantially different patient sizes, examination settings and workflow requirements encountered across veterinary medicine.
Key Findings
Digital radiography remains the most widely deployed routine veterinary imaging modality
Ultrasound provides real-time imaging across increasingly diverse veterinary clinical applications
Advanced CT and MRI adoption centers on specialty and referral care
Portable imaging systems are expanding equine and field diagnostic workflows
Integrated PACS increasingly connects image acquisition interpretation and clinical workflow
Market Trends
Veterinary Diagnostic Imaging is moving from standalone imaging hardware toward increasingly digital, connected and veterinary-specific systems. In radiography, direct digital radiography is progressively replacing older analog and computed-radiography workflows as clinics prioritize faster image acquisition, immediate image review and easier integration with digital archives. Ultrasound systems are simultaneously becoming more portable, with handheld and compact platforms widening access beyond specialist imaging departments. At the higher end of the market, dedicated veterinary MRI and CT platforms are being engineered around animal anatomy, smaller installation footprints and more standardized veterinary protocols, while equine imaging is developing highly specialized standing and mobile solutions. Across modalities, DICOM connectivity, PACS, cloud-based image access, remote interpretation and software-assisted workflow are becoming increasingly important components of system differentiation rather than secondary accessories.
Market Dynamics
Drivers
Demand for Veterinary Diagnostic Imaging is supported by the continued advancement of companion-animal healthcare, greater use of specialist veterinary services and rising expectations for earlier and more definitive diagnosis. Radiography and ultrasound are core diagnostic tools because they address complementary clinical needs: radiography provides rapid assessment of skeletal structures, thoracic conditions and overall anatomical relationships, while ultrasound enables real-time evaluation of soft tissues, blood flow, cardiac function and image-guided procedures. Expansion of veterinary oncology, orthopedics, neurology, emergency medicine and cardiology further increases the clinical value of CT, MRI and advanced ultrasound. Equine practices also create distinct demand for portable radiography, ultrasound and dedicated standing imaging systems where transporting the animal to a conventional imaging suite may be impractical.
Restraints
The main restraint is the substantial difference in economic feasibility between routine and advanced imaging modalities. Digital radiography and portable ultrasound can be incorporated into a relatively broad range of veterinary practices, whereas CT, MRI and nuclear imaging typically require significantly higher equipment investment, specialized installation, maintenance capabilities and clinical expertise. Advanced examinations may also require anesthesia or sedation, dedicated patient handling and trained image interpretation, which can reduce utilization rates in lower-volume practices. The heterogeneous anatomy of different species creates additional requirements for probes, coils, positioning systems, imaging protocols and software optimization, increasing product-development complexity and limiting the extent to which standardized human medical imaging platforms can be transferred directly into veterinary environments.
Opportunities
The largest structural opportunity lies in expanding sophisticated imaging capability beyond large referral hospitals. Compact DR systems, portable X-ray generators, handheld and portable ultrasound, lower-footprint veterinary CT and dedicated MRI platforms can enable general veterinary practices and regional specialty clinics to internalize procedures previously referred externally. Emerging markets also provide opportunities for equipment suppliers able to combine competitive acquisition costs with reliable image quality, service support and simplified workflows. In parallel, integrating imaging hardware with PACS, cloud archives and remote specialist interpretation can increase equipment utilization and diagnostic confidence, particularly where board-certified veterinary radiologists are not available on site. Equine and large-animal imaging represents another differentiated opportunity because mobility and species-specific system design can create substantial value beyond conventional hospital-based equipment.
Challenges
Veterinary imaging manufacturers must balance image quality, clinical functionality and affordability across customers whose procedure volumes and purchasing power vary substantially. Species diversity makes protocol standardization more difficult than in human imaging and requires extensive optimization for different body sizes, anatomical regions and clinical indications. At the same time, advanced equipment has relatively long replacement cycles, making new-system sales dependent on both new-site installations and convincing existing users that workflow, dose, portability or image-quality improvements justify upgrades. Manufacturers also face growing expectations for local technical service, operator education, software updates and interoperability. As hardware performance converges in mature modalities, sustaining differentiation increasingly depends on veterinary-specific workflow design and long-term customer support rather than imaging specifications alone.
Industry Chain Analysis
The Veterinary Diagnostic Imaging industry chain begins with specialized imaging components and technologies, including X-ray tubes and high-frequency generators, flat-panel detectors, ultrasound transducers, signal-processing electronics, CT detectors and gantries, MRI magnets, gradient systems and radio-frequency coils, gamma-camera components, computing hardware and image-processing software. Midstream suppliers integrate these components into veterinary radiography, ultrasound, CT, MRI and nuclear imaging platforms and adapt system mechanics, patient tables, probes, coils, positioning tools and software protocols to different animal species. System integration, calibration, image-processing algorithms, regulatory quality management and veterinary workflow optimization are major value-creation activities. Downstream demand originates from veterinary hospitals, general practices, specialist and referral centers, diagnostic imaging centers, equine practices, universities, research institutions and other animal-care facilities. Beyond initial equipment sales, installation, maintenance, operator training, software integration and technical support materially influence customer purchasing decisions and lifecycle value.
Segment Insights
Routine Veterinary Diagnostic Imaging remains centered on digital radiography and ultrasound because both modalities combine broad clinical utility with relatively accessible installation and workflow requirements. Radiography is the most established imaging modality in veterinary medicine and is widely used for skeletal, thoracic and abdominal examinations, while ultrasound adds real-time soft-tissue, cardiac, vascular and interventional capabilities. Within these categories, the product mix is shifting toward wireless DR detectors, compact systems and portable or handheld platforms that shorten examination workflows and enable imaging outside dedicated radiology rooms.
CT and MRI occupy a more specialized segment but offer higher diagnostic capability for complex neurological, orthopedic, oncological and cross-sectional imaging applications. Dedicated veterinary systems are reducing some historical barriers through species-specific designs, more compact configurations and optimized examination protocols. Nuclear medicine and scintigraphy remain narrower specialist modalities, with applications such as bone, thyroid, renal and equine examinations. From an animal-segment perspective, companion animals form the broadest addressable clinical base, while equine imaging supports a distinct equipment ecosystem emphasizing mobility, standing examinations and specialized musculoskeletal diagnosis.
Downstream Market Opportunities
Veterinary hospitals and specialty or referral centers represent the primary opportunity for multi-modality imaging investment because they handle higher case complexity and can support CT, MRI and advanced ultrasound utilization. General veterinary clinics create broader unit demand for digital radiography and ultrasound, particularly where equipment is positioned as an in-house diagnostic capability that reduces external referrals and accelerates clinical decision-making. Increasing integration between image acquisition and PACS also allows smaller facilities to capture images locally while accessing specialist interpretation remotely, expanding the practical addressable market for imaging hardware.
Outside companion-animal practice, equine medicine offers an important specialized opportunity for portable DR, ultrasound, standing MRI, standing CT and scintigraphy. Farm and livestock environments favor robust portable ultrasound and radiographic solutions where mobility, battery operation and rapid setup are important purchasing considerations. Universities, veterinary schools and research institutions support demand for advanced and multi-modality systems, while zoos and wildlife-care organizations create smaller but technically demanding applications requiring flexible equipment capable of accommodating unusually diverse anatomy and patient sizes.
Regional Insights
North America represents a highly developed Veterinary Diagnostic Imaging environment characterized by extensive companion-animal healthcare infrastructure, specialist referral practices, teleradiology and broad availability of digital imaging technologies. The market increasingly values integrated imaging ecosystems combining equipment, PACS, education, technical support and specialist interpretation. Europe similarly supports advanced veterinary imaging adoption and has a strong supplier base in veterinary radiography, MRI, CT and nuclear imaging, with dedicated systems addressing both companion-animal and equine applications.
Asia-Pacific presents a different opportunity profile, combining rapidly modernizing veterinary clinics with a growing regional manufacturing base for ultrasound and other imaging platforms. Product affordability, portability and scalable system configurations are particularly important for expanding penetration beyond major metropolitan specialty hospitals. Latin America, the Middle East and Africa remain more heterogeneous, with demand generally weighted toward clinically versatile and lower-investment modalities such as digital radiography and ultrasound, while CT and MRI adoption is more concentrated in larger urban hospitals and referral centers.
Competitive Landscape Analysis
The competitive landscape is fragmented by imaging modality rather than dominated by a single universal supplier. Companies with broad veterinary diagnostic platforms increasingly compete through integrated hardware, imaging software, PACS, education and support, while modality specialists differentiate through deeper expertise in radiography, ultrasound, MRI, CT or nuclear medicine. IDEXX combines veterinary digital radiography with dedicated PACS infrastructure, while Antech has developed a broader imaging ecosystem spanning digital radiography, ultrasound, CT-related solutions, PACS and specialist interpretation. The integration of the former Heska business into Mars Petcare's Science & Diagnostics organization has further consolidated Antech's position across veterinary diagnostics, imaging and technology.
A second competitive group is built around specialized imaging technology. Esaote and Hallmarq focus strongly on veterinary MRI and other advanced imaging applications; SEDECAL, EXAMION and OR Technology have established veterinary radiography portfolios, with OR Technology additionally combining X-ray, ultrasound and PACS; MiE addresses the specialized veterinary scintigraphy market. Asian manufacturers including Mindray Animal, SonoScape, Edan, Kaixin and CHISON broaden competition in ultrasound and increasingly portable imaging solutions. As core hardware becomes more widely available, competitive advantage is shifting toward veterinary-specific protocols, mobility, installation economics, image-processing quality, system interoperability and post-sale technical support rather than equipment specifications alone.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Veterinary Diagnostic Imaging market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
GE
IDEXX Laboratories
Esaote
Antech Diagnostics
Carestream Health
E.I. Medical
Mindray
Hallmarq Veterinary Imaging
Sedecal
Kaixin Electric
Chison
MinXray
FUJIFILM Corporation
SonoScape
Oehm und Rehbein GmbH
EXAMION GmbH
Segment by Type
X-ray Imaging Systems
Ultrasound
MRI
Other
Segment by Installation and Mobility
Fixed Imaging Systems
Mobile-based Imaging Systems
Portable Imaging Systems
Segment by End Users
Veterinary Hospitals and Specialty/Referral Centers
Veterinary Clinics
Veterinary Diagnostic Imaging Centers
Other
Segment by Application
Livestock
Pet
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Veterinary Diagnostic Imaging study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Veterinary Diagnostic Imaging: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Veterinary Diagnostic Imaging Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 X-ray Imaging Systems
1.2.3 Ultrasound
1.2.4 MRI
1.2.5 Other
1.3 Market Segmentation by Installation and Mobility
1.3.1 Global Veterinary Diagnostic Imaging Market Size by Installation and Mobility, 2021 vs 2025 vs 2032
1.3.2 Fixed Imaging Systems
1.3.3 Mobile-based Imaging Systems
1.3.4 Portable Imaging Systems
1.4 Market Segmentation by End Users
1.4.1 Global Veterinary Diagnostic Imaging Market Size by End Users, 2021 vs 2025 vs 2032
1.4.2 Veterinary Hospitals and Specialty/Referral Centers
1.4.3 Veterinary Clinics
1.4.4 Veterinary Diagnostic Imaging Centers
1.4.5 Other
1.5 Market Segmentation by Application
1.5.1 Global Veterinary Diagnostic Imaging Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Livestock
1.5.3 Pet
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Veterinary Diagnostic Imaging Revenue Estimates and Forecasts (2021-2032)
2.2 Global Veterinary Diagnostic Imaging Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Veterinary Diagnostic Imaging Sales Estimates and Forecasts (2021-2032)
2.4 Global Veterinary Diagnostic Imaging Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Veterinary Diagnostic Imaging Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Veterinary Diagnostic Imaging Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 X-ray Imaging Systems: Market Share by Key Manufacturers
3.5.2 Ultrasound: Market Share by Key Manufacturers
3.5.3 MRI: Market Share by Key Manufacturers
3.5.4 Other: Market Share by Key Manufacturers
3.6 Global Veterinary Diagnostic Imaging Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Veterinary Diagnostic Imaging Sales Performance by Type
4.1.1 Global Veterinary Diagnostic Imaging Sales Volume by Type (2021-2032)
4.1.2 Global Veterinary Diagnostic Imaging Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Veterinary Diagnostic Imaging Sales Performance by Installation and Mobility
4.2.1 Global Veterinary Diagnostic Imaging Sales Volume by Installation and Mobility (2021-2032)
4.2.2 Global Veterinary Diagnostic Imaging Revenue by Installation and Mobility (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Installation and Mobility (2021-2032)
4.3 Global Veterinary Diagnostic Imaging Sales Performance by End Users
4.3.1 Global Veterinary Diagnostic Imaging Sales Volume by End Users (2021-2032)
4.3.2 Global Veterinary Diagnostic Imaging Revenue by End Users (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by End Users (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Veterinary Diagnostic Imaging Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Veterinary Diagnostic Imaging Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Veterinary Diagnostic Imaging Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Veterinary Diagnostic Imaging Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Veterinary Diagnostic Imaging Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Veterinary Diagnostic Imaging Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Veterinary Diagnostic Imaging Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Veterinary Diagnostic Imaging Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Veterinary Diagnostic Imaging Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Veterinary Diagnostic Imaging Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Veterinary Diagnostic Imaging Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Veterinary Diagnostic Imaging Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 GE
11.1.1 GE Corporation Information
11.1.2 GE Business Overview
11.1.3 GE Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.1.4 GE Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 GE Veterinary Diagnostic Imaging Sales by Product in 2025
11.1.6 GE Veterinary Diagnostic Imaging Sales by Application in 2025
11.1.7 GE Veterinary Diagnostic Imaging Sales by Geographic Area in 2025
11.1.8 GE Veterinary Diagnostic Imaging SWOT Analysis
11.1.9 GE Recent Developments
11.2 IDEXX Laboratories
11.2.1 IDEXX Laboratories Corporation Information
11.2.2 IDEXX Laboratories Business Overview
11.2.3 IDEXX Laboratories Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.2.4 IDEXX Laboratories Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 IDEXX Laboratories Veterinary Diagnostic Imaging Sales by Product in 2025
11.2.6 IDEXX Laboratories Veterinary Diagnostic Imaging Sales by Application in 2025
11.2.7 IDEXX Laboratories Veterinary Diagnostic Imaging Sales by Geographic Area in 2025
11.2.8 IDEXX Laboratories Veterinary Diagnostic Imaging SWOT Analysis
11.2.9 IDEXX Laboratories Recent Developments
11.3 Esaote
11.3.1 Esaote Corporation Information
11.3.2 Esaote Business Overview
11.3.3 Esaote Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.3.4 Esaote Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Esaote Veterinary Diagnostic Imaging Sales by Product in 2025
11.3.6 Esaote Veterinary Diagnostic Imaging Sales by Application in 2025
11.3.7 Esaote Veterinary Diagnostic Imaging Sales by Geographic Area in 2025
11.3.8 Esaote Veterinary Diagnostic Imaging SWOT Analysis
11.3.9 Esaote Recent Developments
11.4 Antech Diagnostics
11.4.1 Antech Diagnostics Corporation Information
11.4.2 Antech Diagnostics Business Overview
11.4.3 Antech Diagnostics Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.4.4 Antech Diagnostics Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Antech Diagnostics Veterinary Diagnostic Imaging Sales by Product in 2025
11.4.6 Antech Diagnostics Veterinary Diagnostic Imaging Sales by Application in 2025
11.4.7 Antech Diagnostics Veterinary Diagnostic Imaging Sales by Geographic Area in 2025
11.4.8 Antech Diagnostics Veterinary Diagnostic Imaging SWOT Analysis
11.4.9 Antech Diagnostics Recent Developments
11.5 Carestream Health
11.5.1 Carestream Health Corporation Information
11.5.2 Carestream Health Business Overview
11.5.3 Carestream Health Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.5.4 Carestream Health Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Carestream Health Veterinary Diagnostic Imaging Sales by Product in 2025
11.5.6 Carestream Health Veterinary Diagnostic Imaging Sales by Application in 2025
11.5.7 Carestream Health Veterinary Diagnostic Imaging Sales by Geographic Area in 2025
11.5.8 Carestream Health Veterinary Diagnostic Imaging SWOT Analysis
11.5.9 Carestream Health Recent Developments
11.6 E.I. Medical
11.6.1 E.I. Medical Corporation Information
11.6.2 E.I. Medical Business Overview
11.6.3 E.I. Medical Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.6.4 E.I. Medical Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 E.I. Medical Recent Developments
11.7 Mindray
11.7.1 Mindray Corporation Information
11.7.2 Mindray Business Overview
11.7.3 Mindray Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.7.4 Mindray Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Mindray Recent Developments
11.8 Hallmarq Veterinary Imaging
11.8.1 Hallmarq Veterinary Imaging Corporation Information
11.8.2 Hallmarq Veterinary Imaging Business Overview
11.8.3 Hallmarq Veterinary Imaging Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.8.4 Hallmarq Veterinary Imaging Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Hallmarq Veterinary Imaging Recent Developments
11.9 Sedecal
11.9.1 Sedecal Corporation Information
11.9.2 Sedecal Business Overview
11.9.3 Sedecal Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.9.4 Sedecal Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Sedecal Recent Developments
11.10 Kaixin Electric
11.10.1 Kaixin Electric Corporation Information
11.10.2 Kaixin Electric Business Overview
11.10.3 Kaixin Electric Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.10.4 Kaixin Electric Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Kaixin Electric Recent Developments
11.11 Chison
11.11.1 Chison Corporation Information
11.11.2 Chison Business Overview
11.11.3 Chison Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.11.4 Chison Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Chison Recent Developments
11.12 MinXray
11.12.1 MinXray Corporation Information
11.12.2 MinXray Business Overview
11.12.3 MinXray Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.12.4 MinXray Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 MinXray Recent Developments
11.13 FUJIFILM Corporation
11.13.1 FUJIFILM Corporation Corporation Information
11.13.2 FUJIFILM Corporation Business Overview
11.13.3 FUJIFILM Corporation Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.13.4 FUJIFILM Corporation Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 FUJIFILM Corporation Recent Developments
11.14 SonoScape
11.14.1 SonoScape Corporation Information
11.14.2 SonoScape Business Overview
11.14.3 SonoScape Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.14.4 SonoScape Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 SonoScape Recent Developments
11.15 Oehm und Rehbein GmbH
11.15.1 Oehm und Rehbein GmbH Corporation Information
11.15.2 Oehm und Rehbein GmbH Business Overview
11.15.3 Oehm und Rehbein GmbH Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.15.4 Oehm und Rehbein GmbH Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Oehm und Rehbein GmbH Recent Developments
11.16 EXAMION GmbH
11.16.1 EXAMION GmbH Corporation Information
11.16.2 EXAMION GmbH Business Overview
11.16.3 EXAMION GmbH Veterinary Diagnostic Imaging Product Models, Descriptions and Specifications
11.16.4 EXAMION GmbH Veterinary Diagnostic Imaging Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 EXAMION GmbH Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Veterinary Diagnostic Imaging Industry Chain
12.2 Veterinary Diagnostic Imaging Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Veterinary Diagnostic Imaging Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Veterinary Diagnostic Imaging Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Veterinary Diagnostic Imaging Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Veterinary Diagnostic Imaging Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Veterinary Diagnostic Imaging Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Veterinary Diagnostic Imaging Market Size Growth Rate by Installation and Mobility, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Veterinary Diagnostic Imaging Market Size Growth Rate by End Users, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Veterinary Diagnostic Imaging Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Veterinary Diagnostic Imaging Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Veterinary Diagnostic Imaging Revenue by Region (US$ Million), 2021-2026
Table 7. Global Veterinary Diagnostic Imaging Revenue by Region (US$ Million), 2027-2032
Table 8. Global Veterinary Diagnostic Imaging Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Veterinary Diagnostic Imaging Sales by Region (K Units), 2021-2026
Table 10. Global Veterinary Diagnostic Imaging Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Veterinary Diagnostic Imaging Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Veterinary Diagnostic Imaging Sales Share by Manufacturers (2021-2026)
Table 14. Global Veterinary Diagnostic Imaging Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Veterinary Diagnostic Imaging Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Veterinary Diagnostic Imaging Revenue, 2025
Table 18. Global Veterinary Diagnostic Imaging Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Veterinary Diagnostic Imaging Average Selling Price (ASP) by Manufacturers (USD/Unit), 2021-2026
Table 20. Key Manufacturers Veterinary Diagnostic Imaging Manufacturing Base and Headquarters
Table 21. Global Veterinary Diagnostic Imaging Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Veterinary Diagnostic Imaging Sales Volume by Type (K Units), 2021-2026
Table 25. Global Veterinary Diagnostic Imaging Sales Volume by Type (K Units), 2027-2032
Table 26. Global Veterinary Diagnostic Imaging Revenue by Type (US$ Million), 2021-2026
Table 27. Global Veterinary Diagnostic Imaging Revenue by Type (US$ Million), 2027-2032
Table 28. Global Veterinary Diagnostic Imaging Sales Volume by Installation and Mobility (K Units), 2021-2026
Table 29. Global Veterinary Diagnostic Imaging Sales Volume by Installation and Mobility (K Units), 2027-2032
Table 30. Global Veterinary Diagnostic Imaging Revenue by Installation and Mobility (US$ Million), 2021-2026
Table 31. Global Veterinary Diagnostic Imaging Revenue by Installation and Mobility (US$ Million), 2027-2032
Table 32. Global Veterinary Diagnostic Imaging Sales Volume by End Users (K Units), 2021-2026
Table 33. Global Veterinary Diagnostic Imaging Sales Volume by End Users (K Units), 2027-2032
Table 34. Global Veterinary Diagnostic Imaging Revenue by End Users (US$ Million), 2021-2026
Table 35. Global Veterinary Diagnostic Imaging Revenue by End Users (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Veterinary Diagnostic Imaging Sales by Application (K Units), 2021-2026
Table 38. Global Veterinary Diagnostic Imaging Sales by Application (K Units), 2027-2032
Table 39. Veterinary Diagnostic Imaging High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Veterinary Diagnostic Imaging Revenue by Application (US$ Million), 2021-2026
Table 41. Global Veterinary Diagnostic Imaging Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Veterinary Diagnostic Imaging Growth Accelerators and Market Barriers
Table 45. North America Veterinary Diagnostic Imaging Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Veterinary Diagnostic Imaging Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Veterinary Diagnostic Imaging Growth Accelerators and Market Barriers
Table 48. Europe Veterinary Diagnostic Imaging Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Veterinary Diagnostic Imaging Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Veterinary Diagnostic Imaging Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Veterinary Diagnostic Imaging Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Veterinary Diagnostic Imaging Growth Accelerators and Market Barriers
Table 53. Southeast Asia Veterinary Diagnostic Imaging Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Veterinary Diagnostic Imaging Investment Opportunities and Key Challenges
Table 55. Central and South America Veterinary Diagnostic Imaging Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Veterinary Diagnostic Imaging Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Veterinary Diagnostic Imaging Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. GE Corporation Information
Table 59. GE Description and Major Businesses
Table 60. GE Product Models, Descriptions and Specifications
Table 61. GE Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 62. GE Sales Value Proportion by Product in 2025
Table 63. GE Sales Value Proportion by Application in 2025
Table 64. GE Sales Value Proportion by Geographic Area in 2025
Table 65. GE Veterinary Diagnostic Imaging SWOT Analysis
Table 66. GE Recent Developments
Table 67. IDEXX Laboratories Corporation Information
Table 68. IDEXX Laboratories Description and Major Businesses
Table 69. IDEXX Laboratories Product Models, Descriptions and Specifications
Table 70. IDEXX Laboratories Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 71. IDEXX Laboratories Sales Value Proportion by Product in 2025
Table 72. IDEXX Laboratories Sales Value Proportion by Application in 2025
Table 73. IDEXX Laboratories Sales Value Proportion by Geographic Area in 2025
Table 74. IDEXX Laboratories Veterinary Diagnostic Imaging SWOT Analysis
Table 75. IDEXX Laboratories Recent Developments
Table 76. Esaote Corporation Information
Table 77. Esaote Description and Major Businesses
Table 78. Esaote Product Models, Descriptions and Specifications
Table 79. Esaote Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 80. Esaote Sales Value Proportion by Product in 2025
Table 81. Esaote Sales Value Proportion by Application in 2025
Table 82. Esaote Sales Value Proportion by Geographic Area in 2025
Table 83. Esaote Veterinary Diagnostic Imaging SWOT Analysis
Table 84. Esaote Recent Developments
Table 85. Antech Diagnostics Corporation Information
Table 86. Antech Diagnostics Description and Major Businesses
Table 87. Antech Diagnostics Product Models, Descriptions and Specifications
Table 88. Antech Diagnostics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 89. Antech Diagnostics Sales Value Proportion by Product in 2025
Table 90. Antech Diagnostics Sales Value Proportion by Application in 2025
Table 91. Antech Diagnostics Sales Value Proportion by Geographic Area in 2025
Table 92. Antech Diagnostics Veterinary Diagnostic Imaging SWOT Analysis
Table 93. Antech Diagnostics Recent Developments
Table 94. Carestream Health Corporation Information
Table 95. Carestream Health Description and Major Businesses
Table 96. Carestream Health Product Models, Descriptions and Specifications
Table 97. Carestream Health Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 98. Carestream Health Sales Value Proportion by Product in 2025
Table 99. Carestream Health Sales Value Proportion by Application in 2025
Table 100. Carestream Health Sales Value Proportion by Geographic Area in 2025
Table 101. Carestream Health Veterinary Diagnostic Imaging SWOT Analysis
Table 102. Carestream Health Recent Developments
Table 103. E.I. Medical Corporation Information
Table 104. E.I. Medical Description and Major Businesses
Table 105. E.I. Medical Product Models, Descriptions and Specifications
Table 106. E.I. Medical Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 107. E.I. Medical Recent Developments
Table 108. Mindray Corporation Information
Table 109. Mindray Description and Major Businesses
Table 110. Mindray Product Models, Descriptions and Specifications
Table 111. Mindray Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 112. Mindray Recent Developments
Table 113. Hallmarq Veterinary Imaging Corporation Information
Table 114. Hallmarq Veterinary Imaging Description and Major Businesses
Table 115. Hallmarq Veterinary Imaging Product Models, Descriptions and Specifications
Table 116. Hallmarq Veterinary Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 117. Hallmarq Veterinary Imaging Recent Developments
Table 118. Sedecal Corporation Information
Table 119. Sedecal Description and Major Businesses
Table 120. Sedecal Product Models, Descriptions and Specifications
Table 121. Sedecal Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 122. Sedecal Recent Developments
Table 123. Kaixin Electric Corporation Information
Table 124. Kaixin Electric Description and Major Businesses
Table 125. Kaixin Electric Product Models, Descriptions and Specifications
Table 126. Kaixin Electric Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 127. Kaixin Electric Recent Developments
Table 128. Chison Corporation Information
Table 129. Chison Description and Major Businesses
Table 130. Chison Product Models, Descriptions and Specifications
Table 131. Chison Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 132. Chison Recent Developments
Table 133. MinXray Corporation Information
Table 134. MinXray Description and Major Businesses
Table 135. MinXray Product Models, Descriptions and Specifications
Table 136. MinXray Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 137. MinXray Recent Developments
Table 138. FUJIFILM Corporation Corporation Information
Table 139. FUJIFILM Corporation Description and Major Businesses
Table 140. FUJIFILM Corporation Product Models, Descriptions and Specifications
Table 141. FUJIFILM Corporation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 142. FUJIFILM Corporation Recent Developments
Table 143. SonoScape Corporation Information
Table 144. SonoScape Description and Major Businesses
Table 145. SonoScape Product Models, Descriptions and Specifications
Table 146. SonoScape Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 147. SonoScape Recent Developments
Table 148. Oehm und Rehbein GmbH Corporation Information
Table 149. Oehm und Rehbein GmbH Description and Major Businesses
Table 150. Oehm und Rehbein GmbH Product Models, Descriptions and Specifications
Table 151. Oehm und Rehbein GmbH Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 152. Oehm und Rehbein GmbH Recent Developments
Table 153. EXAMION GmbH Corporation Information
Table 154. EXAMION GmbH Description and Major Businesses
Table 155. EXAMION GmbH Product Models, Descriptions and Specifications
Table 156. EXAMION GmbH Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 157. EXAMION GmbH Recent Developments
Table 158. Key Raw Materials Distribution
Table 159. Raw Materials Key Suppliers
Table 160. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 161. Milestones in Production Technology Evolution
Table 162. Distributors List
Table 163. Market Trends and Market Evolution
Table 164. Market Drivers and Opportunities
Table 165. Market Challenges, Risks, and Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources

List of Figures
Figure 1. Veterinary Diagnostic Imaging Product Picture
Figure 2. Global Veterinary Diagnostic Imaging Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. X-ray Imaging Systems Product Picture
Figure 4. Ultrasound Product Picture
Figure 5. MRI Product Picture
Figure 6. Other Product Picture
Figure 7. Global Veterinary Diagnostic Imaging Market Size Growth Rate by Installation and Mobility, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Fixed Imaging Systems Product Picture
Figure 9. Mobile-based Imaging Systems Product Picture
Figure 10. Portable Imaging Systems Product Picture
Figure 11. Global Veterinary Diagnostic Imaging Market Size Growth Rate by End Users, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Veterinary Hospitals and Specialty/Referral Centers Product Picture
Figure 13. Veterinary Clinics Product Picture
Figure 14. Veterinary Diagnostic Imaging Centers Product Picture
Figure 15. Other Product Picture
Figure 16. Global Veterinary Diagnostic Imaging Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 17. Livestock
Figure 18. Pet
Figure 19. Veterinary Diagnostic Imaging Report Years Considered
Figure 20. Global Veterinary Diagnostic Imaging Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 22. Global Veterinary Diagnostic Imaging Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 23. Global Veterinary Diagnostic Imaging Revenue-Based Market Share by Region (2021-2032)
Figure 24. Global Veterinary Diagnostic Imaging Sales (K Units), 2021-2032
Figure 25. Global Veterinary Diagnostic Imaging Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 26. Global Veterinary Diagnostic Imaging Sales Market Share by Region (2021-2032)
Figure 27. Top 5 and Top 10 Manufacturers Veterinary Diagnostic Imaging Sales Volume Market Share in 2025
Figure 28. Global Veterinary Diagnostic Imaging Revenue-Based Market Share Ranking (2025)
Figure 29. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 30. X-ray Imaging Systems Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Ultrasound Revenue-Based Market Share by Manufacturer in 2025
Figure 32. MRI Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Global Veterinary Diagnostic Imaging Sales Volume-Based Market Share by Type (2021-2032)
Figure 35. Global Veterinary Diagnostic Imaging Revenue-Based Market Share by Type (2021-2032)
Figure 36. Global Veterinary Diagnostic Imaging ASP by Type (USD/Unit), 2021-2032
Figure 37. Global Veterinary Diagnostic Imaging Sales Volume-Based Market Share by Installation and Mobility (2021-2032)
Figure 38. Global Veterinary Diagnostic Imaging Revenue-Based Market Share by Installation and Mobility (2021-2032)
Figure 39. Global Veterinary Diagnostic Imaging ASP by Installation and Mobility (USD/Unit), 2021-2032
Figure 40. Global Veterinary Diagnostic Imaging Sales Volume-Based Market Share by End Users (2021-2032)
Figure 41. Global Veterinary Diagnostic Imaging Revenue-Based Market Share by End Users (2021-2032)
Figure 42. Global Veterinary Diagnostic Imaging ASP by End Users (USD/Unit), 2021-2032
Figure 43. Global Veterinary Diagnostic Imaging Sales Market Share by Application (2021-2032)
Figure 44. Global Veterinary Diagnostic Imaging Revenue-Based Market Share by Application (2021-2032)
Figure 45. Global Veterinary Diagnostic Imaging ASP by Application (USD/Unit), 2021-2032
Figure 46. North America Veterinary Diagnostic Imaging Sales YoY (K Units), 2021-2032
Figure 47. North America Veterinary Diagnostic Imaging Revenue YoY (US$ Million), 2021-2032
Figure 48. North America Top 5 Manufacturers Veterinary Diagnostic Imaging Sales Revenue (US$ Million) in 2025
Figure 49. North America Veterinary Diagnostic Imaging Sales Volume (K Units) by Application (2021-2032)
Figure 50. North America Veterinary Diagnostic Imaging Sales Revenue (US$ Million) by Application (2021-2032)
Figure 51. US Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 52. Canada Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 53. Mexico Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 54. Europe Veterinary Diagnostic Imaging Sales YoY (K Units), 2021-2032
Figure 55. Europe Veterinary Diagnostic Imaging Revenue YoY (US$ Million), 2021-2032
Figure 56. Europe Top 5 Manufacturers Veterinary Diagnostic Imaging Sales Revenue (US$ Million) in 2025
Figure 57. Europe Veterinary Diagnostic Imaging Sales Volume (K Units) by Application (2021-2032)
Figure 58. Europe Veterinary Diagnostic Imaging Sales Revenue (US$ Million) by Application (2021-2032)
Figure 59. Germany Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 60. France Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 61. U.K. Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 62. Italy Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 63. Russia Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 64. Asia-Pacific Veterinary Diagnostic Imaging Sales YoY (K Units), 2021-2032
Figure 65. Asia-Pacific Veterinary Diagnostic Imaging Revenue YoY (US$ Million), 2021-2032
Figure 66. Asia-Pacific Top 8 Manufacturers Veterinary Diagnostic Imaging Sales Revenue (US$ Million) in 2025
Figure 67. Asia-Pacific Veterinary Diagnostic Imaging Sales Volume (K Units) by Application (2021-2032)
Figure 68. Asia-Pacific Veterinary Diagnostic Imaging Sales Revenue (US$ Million) by Application (2021-2032)
Figure 69. Indonesia Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 70. Japan Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 71. South Korea Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 72. China Taiwan Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 73. India Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 74. Central and South America Veterinary Diagnostic Imaging Sales YoY (K Units), 2021-2032
Figure 75. Central and South America Veterinary Diagnostic Imaging Revenue YoY (US$ Million), 2021-2032
Figure 76. Central and South America Top 5 Manufacturers Veterinary Diagnostic Imaging Sales Revenue (US$ Million) in 2025
Figure 77. Central and South America Veterinary Diagnostic Imaging Sales Volume (K Units) by Application (2021-2032)
Figure 78. Central and South America Veterinary Diagnostic Imaging Sales Revenue (US$ Million) by Application (2021-2032)
Figure 79. Brazil Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 80. Argentina Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 81. Middle East, and Africa Veterinary Diagnostic Imaging Sales YoY (K Units), 2021-2032
Figure 82. Middle East and Africa Veterinary Diagnostic Imaging Revenue YoY (US$ Million), 2021-2032
Figure 83. Middle East and Africa Top 5 Manufacturers Veterinary Diagnostic Imaging Sales Revenue (US$ Million) in 2025
Figure 84. Middle East and Africa Veterinary Diagnostic Imaging Sales Volume (K Units) by Application (2021-2032)
Figure 85. Middle East and Africa Veterinary Diagnostic Imaging Sales Revenue (US$ Million) by Application (2021-2032)
Figure 86. GCC Countries Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 87. Turkey Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 88. Egypt Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 89. South Africa Veterinary Diagnostic Imaging Revenue (US$ Million), 2021-2032
Figure 90. Veterinary Diagnostic Imaging Industry Chain Mapping
Figure 91. Regional Veterinary Diagnostic Imaging Manufacturing Base Distribution (%)
Figure 92. Global Veterinary Diagnostic Imaging Production Market Share by Region (2021-2032)
Figure 93. Veterinary Diagnostic Imaging Production Process
Figure 94. Regional Veterinary Diagnostic Imaging Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed